Previous studies have shown that activation of coagulation has an impact on the clinical
course of lung cancer. This study was carried out to assess the potential prognostic …

Activation of coagulation and fibrinolysis is frequently encountered among cancer patients.
Such tumors are supposed to be associated with higher risk of invasion, metastases and …

Both experimental and clinical data have shown that coagulation disorders are common in
patients with cancer although clinical symptoms occur rarely. A prethrombotic state is …

There is a subclinical activation of coagulation and fibrinolysis system in lung cancer.
Alterations in hemostatic system are seen frequently in lung cancer correlated with the …

Abstract Background and Aim Activation of coagulation and fibrinolysis is frequently
encountered among cancer patients. Such tumors are supposed to be associated with …

Forty-eight patients with freshly diagnosed carcinoma of the lung (40 males, 8 females) were
evaluated for a coagulation profile including activated partial thromboplas tin time (aPTT) …

Background Hypercoagulability in lung cancer patients is associated with a high incidence
of mortality and morbidity in the world. Therefore, this meta‐analysis aimed to explore the …

Blood coagulation test results were collected prospectively in patients with previously
untreated, advanced lung or colon cancer who entered into a clinical trial. In patients with …

Background There is evidence that activation of coagulation by influencing tumour biology
may have impact on clinical course of lung cancer. Patients and methods We measured the …

Purpose: To investigate the relationship between coagulation function and prognosis of non-
small cell lung cancer (NSCLC) patients. Methods: 539 patients who were admitted to our …